American Home Products’ former top medical executive triedto strike at the core of a class action over fen-phen last weekby testifying that the risk of heart and lung disease disappearsa year after patients stop taking the diet drugs.
The testimony by Dr. Marc Deitsch, former senior vicepresident of medical affairs at AHP subsidiary Wyeth Laboratorieswho was called by the plaintiffs as a hostile witness, was keybecause the class is made up of people who used the drug but areasymptomatic.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
